Literature DB >> 18780228

Opiates, immune system, acquired immunodeficiency syndrome, and nonhuman primate model.

Richard J Noel1, Vanessa Rivera-Amill, Shilpa Buch, Anil Kumar.   

Abstract

Both human immunodeficiency virus (HIV) and illicit drug addiction remain major health problems not only in the United States but all over globe. The effect of drug addiction on HIV/AIDS (acquired immunodeficiency syndrome) has been somewhat underexplored. However, in United States more than one fourth of HIV-positive individuals are injection drug users. Opiates are known to negatively affect the immune system, and therefore may have deleterious effects on progression of disease among HIV-infected individuals. This review discusses the effects of opiates on immune system as well as its effect on HIV replication and AIDS progression. In addition, the effects of opiates on disease progression in non-human primate model of AIDS is presented with at least one possible reason for rapid disease progression in multi-virus the challenge model.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18780228      PMCID： PMC4086310          DOI： 10.1080/13550280802078209

Source DB:  PubMed          Journal:  J Neurovirol        ISSN： 1355-0284            Impact factor:   2.643


  47 in total

1.  Importance of the nef gene for maintenance of high virus loads and for development of AIDS.

Authors:  H W Kestler; D J Ringler; K Mori; D L Panicali; P K Sehgal; M D Daniel; R C Desrosiers
Journal:  Cell       Date:  1991-05-17       Impact factor: 41.582

Review 2.  Consequences of opiate-dependency in a monkey model of AIDS.

Authors:  R M Donahoe; L D Byrd; H M McClure; P Fultz; M Brantley; F Marsteller; A A Ansari; D Wenzel; M Aceto
Journal:  Adv Exp Med Biol       Date:  1993       Impact factor: 2.622

Review 3.  Enhancement of HIV-1 replication by opiates and cocaine: the cytokine connection.

Authors:  P K Peterson; G Gekker; R Schut; S Hu; H H Balfour; C C Chao
Journal:  Adv Exp Med Biol       Date:  1993       Impact factor: 2.622

4.  Continued drug use and other cofactors for progression to AIDS among injecting drug users.

Authors:  P J Ronald; J R Robertson; R A Elton
Journal:  AIDS       Date:  1994-03       Impact factor: 4.177

Review 5.  The brain-immune axis: role of opiates and other substances of abuse, the hypothalamic-pituitary-adrenal axis and behavior.

Authors:  S Matta; D Saphier; D Lysle; B Sharp
Journal:  Adv Exp Med Biol       Date:  1995       Impact factor: 2.622

6.  Opioid dependency and the progression of simian AIDS: opioid dependency and behavioral observations.

Authors:  K F Killam; L F Chuang; R Y Chuang
Journal:  Adv Exp Med Biol       Date:  1996       Impact factor: 2.622

7.  Increased replication of simian immunodeficiency virus in CEM x174 cells by morphine sulfate.

Authors:  L F Chuang; K F Killam; R Y Chuang
Journal:  Biochem Biophys Res Commun       Date:  1993-09-30       Impact factor: 3.575

8.  Immune alterations in chronic morphine-treated rhesus monkeys.

Authors:  D J Carr; C P France
Journal:  Adv Exp Med Biol       Date:  1993       Impact factor: 2.622

9.  Morphine amplifies HIV-1 expression in chronically infected promonocytes cocultured with human brain cells.

Authors:  P K Peterson; G Gekker; S Hu; W R Anderson; F Kravitz; P S Portoghese; H H Balfour; C C Chao
Journal:  J Neuroimmunol       Date:  1994-03       Impact factor: 3.478

10.  Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients.

Authors:  N J Deacon; A Tsykin; A Solomon; K Smith; M Ludford-Menting; D J Hooker; D A McPhee; A L Greenway; A Ellett; C Chatfield; V A Lawson; S Crowe; A Maerz; S Sonza; J Learmont; J S Sullivan; A Cunningham; D Dwyer; D Dowton; J Mills
Journal:  Science       Date:  1995-11-10       Impact factor: 47.728
View more
  14 in total

1.  Outcomes associated with a cognitive-behavioral chronic pain management program implemented in three public HIV primary care clinics.

Authors:  Jodie A Trafton; John T Sorrell; Mark Holodniy; Heather Pierson; Percy Link; Ann Combs; Dennis Israelski
Journal:  J Behav Health Serv Res       Date:  2012-04       Impact factor: 1.505

Review 2.  Bivalent ligands targeting chemokine receptor dimerization: molecular design and functional studies.

Authors:  Christopher Kent Arnatt; Yan Zhang
Journal:  Curr Top Med Chem       Date:  2014       Impact factor: 3.295

3.  Identification and molecular characterization of SIV Vpr R50G mutation associated with long term survival in SIV-infected morphine dependent and control macaques.

Authors:  Ivelisse Rivera; Yashira García; Mohitkumar R Gangwani; Richard J Noel; Lucianette Maldonado; Anil Kumar; Vanessa Rivera-Amill
Journal:  Virology       Date:  2013-08-28       Impact factor: 3.616

4.  Tolerance to chronic delta-9-tetrahydrocannabinol (Δ⁹-THC) in rhesus macaques infected with simian immunodeficiency virus.

Authors:  Peter J Winsauer; Patricia E Molina; Angela M Amedee; Catalin M Filipeanu; Robin R McGoey; Dana A Troxclair; Edith M Walker; Leslie L Birke; Curtis Vande Stouwe; Jessica M Howard; Stuart T Leonard; Joseph M Moerschbaecher; Peter B Lewis
Journal:  Exp Clin Psychopharmacol       Date:  2011-04       Impact factor: 3.157

5.  Translational research in NeuroAIDS: a neuroimmune pharmacology-related course.

Authors:  Amanda Brown; Bruce Shiramizu; Avindra Nath; Valerie Wojna
Journal:  J Neuroimmune Pharmacol       Date:  2010-05-25       Impact factor: 4.147

6.  Exploration of bivalent ligands targeting putative mu opioid receptor and chemokine receptor CCR5 dimerization.

Authors:  Christopher K Arnatt; Bethany A Falls; Yunyun Yuan; Thomas J Raborg; Ruturaj R Masvekar; Nazira El-Hage; Dana E Selley; Anthony V Nicola; Pamela E Knapp; Kurt F Hauser; Yan Zhang
Journal:  Bioorg Med Chem       Date:  2016-09-26       Impact factor: 3.641

7.  Analysis of the V1V2 region of the SIV envelope in the brains of morphine-dependent and control SIV/SHIV-infected macaques.

Authors:  Vanessa Rivera-Amill; Richard J Noel; Ivelisse Rivera Román; Yashira García Flores; Shilpa Buch; Anil Kumar
Journal:  AIDS Res Hum Retroviruses       Date:  2009-05       Impact factor: 2.205

8.  Update on animal models for HIV research.

Authors:  Nancy L Haigwood
Journal:  Eur J Immunol       Date:  2009-08       Impact factor: 5.532

9.  Morphine Tolerance and Physical Dependence Are Altered in Conditional HIV-1 Tat Transgenic Mice.

Authors:  Sylvia Fitting; David L Stevens; Fayez A Khan; Krista L Scoggins; Rachel M Enga; Patrick M Beardsley; Pamela E Knapp; William L Dewey; Kurt F Hauser
Journal:  J Pharmacol Exp Ther       Date:  2015-11-05       Impact factor: 4.030

10.  Combined HIV-1 Tat and oxycodone activate the hypothalamic-pituitary-adrenal and -gonadal axes and promote psychomotor, affective, and cognitive dysfunction in female mice.

Authors:  Mohammed F Salahuddin; Alaa N Qrareya; Fakhri Mahdi; Dejun Jackson; Matthew Foster; Tamara Vujanovic; J Gaston Box; Jason J Paris
Journal:  Horm Behav       Date:  2019-12-13       Impact factor: 3.587
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.